IL325733A - תרכובת בשאיפה של פלוטיקאזון פרופיונאט ואלבוטרול סולפאט לטיפול באסתמה - Google Patents
תרכובת בשאיפה של פלוטיקאזון פרופיונאט ואלבוטרול סולפאט לטיפול באסתמהInfo
- Publication number
- IL325733A IL325733A IL325733A IL32573326A IL325733A IL 325733 A IL325733 A IL 325733A IL 325733 A IL325733 A IL 325733A IL 32573326 A IL32573326 A IL 32573326A IL 325733 A IL325733 A IL 325733A
- Authority
- IL
- Israel
- Prior art keywords
- asthma
- treatment
- fluticasone propionate
- albuterol sulfate
- inhalable formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363525562P | 2023-07-07 | 2023-07-07 | |
| EP23186753.2A EP4487842A1 (en) | 2023-07-07 | 2023-07-20 | An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma |
| PCT/EP2024/068985 WO2025012114A1 (en) | 2023-07-07 | 2024-07-05 | An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325733A true IL325733A (he) | 2026-03-01 |
Family
ID=91898420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL325733A IL325733A (he) | 2023-07-07 | 2024-07-05 | תרכובת בשאיפה של פלוטיקאזון פרופיונאט ואלבוטרול סולפאט לטיפול באסתמה |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4739294A1 (he) |
| KR (1) | KR20260049792A (he) |
| AU (1) | AU2024287435A1 (he) |
| IL (1) | IL325733A (he) |
| WO (1) | WO2025012114A1 (he) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130125882A1 (en) * | 2011-11-17 | 2013-05-23 | Jonathan Matz | Method and composition for treating asthma and copd |
| MX374870B (es) | 2013-10-07 | 2025-03-06 | Teva Branded Pharmaceutical Products R&D Inc | Inhalador de polvo seco. |
| US10058661B2 (en) | 2014-12-04 | 2018-08-28 | Norton (Waterford) Limited | Inhalation monitoring system and method |
| WO2020222148A1 (en) | 2019-04-30 | 2020-11-05 | Norton (Waterford) Limited | Inhaler system |
| GB202012742D0 (en) * | 2020-08-14 | 2020-09-30 | Norton Waterford Ltd | An inhalable medicament |
-
2024
- 2024-07-05 IL IL325733A patent/IL325733A/he unknown
- 2024-07-05 KR KR1020267004019A patent/KR20260049792A/ko active Pending
- 2024-07-05 AU AU2024287435A patent/AU2024287435A1/en active Pending
- 2024-07-05 WO PCT/EP2024/068985 patent/WO2025012114A1/en not_active Ceased
- 2024-07-05 EP EP24740404.9A patent/EP4739294A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025012114A1 (en) | 2025-01-16 |
| KR20260049792A (ko) | 2026-04-14 |
| EP4739294A1 (en) | 2026-05-13 |
| AU2024287435A1 (en) | 2026-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020086759A3 (en) | Composition and method for treating the lungs | |
| ZA202208111B (en) | Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation | |
| NZ789880A (en) | Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation | |
| PH12016501268B1 (en) | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination | |
| RU2011101151A (ru) | Интраназальные композиции, содержащие деконгестант и кортикостероид | |
| RU2006132038A (ru) | Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей | |
| WO2007099329A3 (en) | Nebulizer formulation | |
| SG11202105291QA (en) | Dry powder inhalation formulation and its use for the therapeutic treatment of lungs | |
| EP4356637A4 (en) | METHOD AND APPARATUS FOR LICENSED ASSISTED ACCESS VIA AN AIR INTERFACE | |
| CA3297699A1 (en) | An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma | |
| CA3297701A1 (en) | An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma | |
| Tamura | Comparison of the aerosol velocity of Respimat® soft mist inhaler and seven pressurized metered dose inhalers | |
| DE102019127564A8 (de) | Verfahren zur Herstellung eines Verdampfers und Verdampfer für einen Inhalator | |
| AU2022407131B2 (en) | New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases | |
| BR112017014861A2 (pt) | ?combinação e composição farmacêuticas, inalador de pó seco, uso de uma combinação farmacêutica, e, método para tratamento de um distúrbio pulmonar? | |
| JP2007518817A5 (he) | ||
| PT4199922T (pt) | Ácido (1r,3s)-3-((5-ciano-4-feniltiazol-2- il)carbamoil)ciclopentano-1-carboxílico para uso no tratamento de doenças das vias respiratórias | |
| IL319208A (he) | טיפול באסתמה עם נוגדן אנטי-אינטרלוקין-33 | |
| EP4410310A4 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR RESPIRATORY DISEASES | |
| GB2609003B (en) | Compounds and pharmaceutical compositions for the treatment of metabolic disorders | |
| GB202100454D0 (en) | Tracheostomy tubes and the manufacture of such tubes and their components | |
| HUP2300099A1 (hu) | Eljárás upadacitinib hatóanyag és intermedierek elõállítására | |
| ZA202302587B (en) | Atomizer for pediatric respiratory tract therapy | |
| AU2022900870A0 (en) | Inhalation formulation for the treatment of respiratory viral infections | |
| AU2020901131A0 (en) | Compositions and methods of treatment of respiratory tract infections |